Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Brooks

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
MMWR. Morbidity and Mortality Weekly Report|August 4, 2022
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022Evelyn Twentyman, Megan Wallace, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|October 19, 2023
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023Joanna J Regan, Danielle L Moulia, Ruth Link-Gelles, et al.
MMWR. Morbidity and Mortality Weekly Report|June 30, 2022
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022Katherine E Fleming-Dutra, Megan Wallace, Danielle L Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|January 20, 2022
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021Sara E Oliver, Megan Wallace, Isaac See, et al.
MMWR. Morbidity and Mortality Weekly Report|March 17, 2022
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022Megan Wallace, Danielle Moulia, Amy E Blain, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
MMWR. Morbidity and Mortality Weekly Report|August 4, 2022
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022Evelyn Twentyman, Megan Wallace, Lauren E Roper, et al.
MMWR. Morbidity and Mortality Weekly Report|October 19, 2023
Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023Joanna J Regan, Danielle L Moulia, Ruth Link-Gelles, et al.
MMWR. Morbidity and Mortality Weekly Report|June 30, 2022
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022Katherine E Fleming-Dutra, Megan Wallace, Danielle L Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|January 20, 2022
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021Sara E Oliver, Megan Wallace, Isaac See, et al.
MMWR. Morbidity and Mortality Weekly Report|March 17, 2022
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022Megan Wallace, Danielle Moulia, Amy E Blain, et al.
Pageof 2